Company / SG&A Expense
Bio Green Med Solution, Inc. SG&A Expense History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$7.7M
FY2025
5-year range
$5.3M / $7.7M
FY2021-FY2025
Trend
+46.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense returned to growth in FY2025 after 5 years of decline, reaching $8M.
Based on SEC 10-K filings.
$8M in FY2025 with a 10-year CAGR of +3.0%.
Increased from $6M to $8M over the past 9 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +3.0%
Key checks
Key Insights
- In FY2025, sg&a expense increased 46.9% year-over-year.
- Peak sg&a expense was recorded in FY2012.
- Lowest sg&a expense in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -47.65 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.7M | +46.9% |
| FY2017 | $5.3M | -4.7% |
| FY2016 | $5.5M | -3.8% |
| FY2015 | $5.7M | -2.7% |
| FY2014 | $5.9M | -24.3% |
| FY2013 | $7.8M | -9.3% |
| FY2012 | $8.6M | +31.2% |
| FY2011 | $6.5M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 22, 2026